ESR1 and breast cancer: This cohort contained a subset of genes that could be considered potential biomarkers for breast cancer progression, including FOXA1, MLPH, ESR1, AR, GATA3, TFF1, THSD4, and TBC1D9 (Supplementary Figure S2B).